These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 7878690)

  • 1. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence.
    Korinthenberg R; Haug C; Hannak D
    Neuropediatrics; 1994 Aug; 25(4):214-6. PubMed ID: 7824094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
    Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A
    Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine and its epoxide: relation of plasma levels to toxicity and seizure control.
    Theodore WH; Narang PK; Holmes MD; Reeves P; Nice FJ
    Ann Neurol; 1989 Feb; 25(2):194-6. PubMed ID: 2919868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
    Tomson T; Svensson JO; Hilton-Brown P
    Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy.
    Camfield P; Hwang P; Camfield C; Fraser A; Soldin S; al-Quadah AK
    Can J Neurol Sci; 1992 May; 19(2):204-7. PubMed ID: 1623447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to carbamazepine in children with newly diagnosed partial onset epilepsy.
    Holland KD; Glauser TA
    Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
    Gupta M; Gupta YK; Agarwal S; Aneja S; Kalaivani M; Kohli K
    Epilepsia; 2004 Dec; 45(12):1636-9. PubMed ID: 15571523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine in trigeminal neuralgia: clinical effects in relation to plasma-concentration.
    Tomson T; Tybring G; Bertilsson L; Ekbom K; Rane A
    Ups J Med Sci Suppl; 1980; 31():45-6. PubMed ID: 6935859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carbamazepine-fluvoxamine interaction. Consequences for the carbamazepine plasma level].
    Cottencin O; Regnaut N; Thévenon-Gignac C; Thomas P; Goudemand M; Debruille C; Robert H
    Encephale; 1995; 21(2):141-5. PubMed ID: 7781585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, placebo-controlled, double-blind study of efficacy of a new form of carbamazepine (Carbatrol) in refractory epileptic patients.
    Sobaniec W; Kułak W; Smigielska-Kuzia J; Boćkowski L; Majkowski J; Jedrzejczak J
    Pol J Pharmacol; 2004; 56(2):195-201. PubMed ID: 15156070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
    Miller AD; Krauss GL; Hamzeh FM
    Acta Neurol Scand; 2004 Jun; 109(6):374-7. PubMed ID: 15147458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine].
    Loiseau P; Cohadon S; Jogeix M; Legroux M; Dartigues JF
    Rev Neurol (Paris); 1984; 140(6-7):434-7. PubMed ID: 6431586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.